• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[识别胎儿-母体出血的可能性]

[Possibility to identify fetomaternal haemorrhage].

作者信息

Studnicková M, L'ubuský M, Ordeltová M, Procházka M

机构信息

Porodnicko-gynekologická klinika FN, Olomouc.

出版信息

Ceska Gynekol. 2010 Oct;75(5):443-6.

PMID:21374922
Abstract

UNLABELLED

Fetomaternal haemorrhage (FMH) is a status characterised by penetration of fetal blood into the maternal circulation which happens mostly at delivery. FMH may cause erythrocytal alloimmunisation of woman. That is why anti-D immunoglobulin (IgG anti-D) is being administered to RhD negative women after delivery of RhD positive fetus. IgG anti-D is administered to RhD negative women standardly and in much greater quantities than is actually necessary. However, on the other hand, it is not possible to diagnose cases where a greater dose is required. To optimalise prevention of RhD alloimmunization in RhD negative women, it is important to diagnose conditions where fetomaternal haemorrhage (FMH) occurs, precisely define its volume and consequently administer the required dose of IgG anti-D. The ability to reliably detect fetomaternal haemorrhage (FMH) and precisely define its volume would allow better and less expensive prevention of RhD alloimmunization in RhD negative women. IgG anti-D could thus be administered only in cases that are actually indicated and only in doses necessary for preventing RhD alloimmunization. Accurate quantification of FMH is determined by flow cytometry.

DESIGN

Review.

SETTING

Department of Obstetrics and Gynecology, Department of Alergology and Clinical Immunology, University Hospital Olomouc.

摘要

未标注

胎儿-母体出血(FMH)是一种以胎儿血液进入母体循环为特征的状态,主要发生在分娩时。FMH可能导致女性红细胞同种免疫。这就是为什么在分娩出RhD阳性胎儿后,要给RhD阴性女性注射抗D免疫球蛋白(IgG抗D)。通常会给RhD阴性女性注射IgG抗D,且注射量远超过实际所需。然而,另一方面,无法诊断出需要更大剂量的情况。为了优化对RhD阴性女性RhD同种免疫的预防,重要的是诊断出发生胎儿-母体出血(FMH)的情况,精确确定其出血量,进而给予所需剂量的IgG抗D。可靠检测胎儿-母体出血(FMH)并精确确定其出血量的能力,将有助于更好且更经济地预防RhD阴性女性的RhD同种免疫。因此,仅在实际有指征的情况下,且仅给予预防RhD同种免疫所需剂量的IgG抗D。FMH的准确量化通过流式细胞术确定。

设计

综述。

背景

奥洛穆茨大学医院妇产科、过敏与临床免疫科。

相似文献

1
[Possibility to identify fetomaternal haemorrhage].[识别胎儿-母体出血的可能性]
Ceska Gynekol. 2010 Oct;75(5):443-6.
2
[Spontaneous antepartal RhD alloimmunization].[自发性产前RhD同种免疫]
Ceska Gynekol. 2015 Dec;80(6):401-4.
3
Prevention of RhD alloimmunization in RhD negative women.RhD阴性女性中RhD同种免疫的预防
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Mar;154(1):3-7. doi: 10.5507/bp.2010.003.
4
[Guideline for prevention of RhD alloimmunizationin RhD negative women].[RhD阴性女性RhD同种免疫预防指南]
Ceska Gynekol. 2013 Apr;78(2):132-3.
5
Detection of fetomaternal hemorrhage.胎儿母体出血的检测。
Am J Hematol. 2012 Apr;87(4):417-23. doi: 10.1002/ajh.22255. Epub 2012 Jan 9.
6
[Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women].[用于RhD阴性女性胎儿-母体出血的抗-D抗体定量流式细胞术检测的标准化]
Ginekol Pol. 2015 Jul;86(7):486-93. doi: 10.17772/gp/57854.
7
[The influence of maternal age, parity, gestational age and birth weight on fetomaternal haemorrhage during spontaneous delivery].[母亲年龄、产次、孕周及出生体重对自然分娩时胎儿-母体出血的影响]
Ceska Gynekol. 2012 Jun;77(3):256-61.
8
Comparison of two techniques for the evaluation of fetomaternal hemorrhage in RhD-negative women: gel agglutination and haemoglobin F determination by flow cytometry.RhD阴性女性胎儿-母体出血评估的两种技术比较:凝胶凝集法和流式细胞术测定血红蛋白F
Acta Obstet Gynecol Scand. 2007;86(7):821-6. doi: 10.1080/00016340701415509.
9
[Fetomaternal haemorrhage in delivery by cesarean section].剖宫产分娩中的胎儿-母体出血
Ceska Gynekol. 2012 Apr;77(2):156-62.
10
[Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].[预防母胎恒河猴-D同种免疫。实际问题]
J Gynecol Obstet Biol Reprod (Paris). 2006 Feb;35(1 Suppl):1S123-1S130.